for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shop Apotheke Europe NV

SAEG.DE

Latest Trade

37.60EUR

Change

-0.05(-0.13%)

Volume

14,392

Today's Range

35.90

 - 

37.95

52 Week Range

28.30

 - 

42.40

As of on the XETRA ∙ Minimum 15 minute delay

Latest Developments

Shop Apotheke Europe 9-month Adjusted Loss After Taxes Widens To EUR 27.8 Million

Nov 14 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-NEWS: SHOP APOTHEKE EUROPE INCREASES GROUP REVENUES BY MORE THAN 30% TO EUR 509 MILLION DURING THE FIRST NINE MONTHS OF 2019..FORECAST FOR 2019 SPECIFIED: REVENUES OF CA. EUR 700 MILLION; ADJUSTED EBITDA MARGIN BETWEEN -2.0% AND -2.3%.9-MONTH EBITDA) ADJUSTED FOR SPECIAL ITEMS AMOUNTED TO EUR -11.7 MILLION AFTER EUR -7.2 MILLION FOR FIRST NINE MONTHS OF 2018.9-MONTH ADJUSTED EARNINGS AFTER TAXES WERE EUR -27.8 MILLION AFTER EUR - 20.0 MILLION FOR CORRESPONDING PERIOD OF 2018..

Shop Apotheke Europe 9-month Revenues Up 31% To Around EUR 509 Million

Oct 11 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-NEWS: SHOP APOTHEKE EUROPE: GROUP REVENUES RISE SIGNIFICANTLY BY +31% TO AROUND EUR 509 MILLION DURING THE FIRST NINE MONTHS OF 2019..EXPECTS A FURTHER INCREASE IN REVENUES DURING Q4 AND CONFIRMS ITS FORECAST FOR 2019 FISCAL YEAR.9MTH REVENUES UP BY 31% TO JUST UNDER EUR 509 MILLION COMPARED TO EUR 388.5 MILLION FOR SAME PERIOD OF PREVIOUS YEAR.

Shop Apotheke Europe H1 Revenues Up 32% To EUR 338 Million

July 9 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-NEWS: SHOP APOTHEKE EUROPE N.V. CONTINUES ITS GROWTH COURSE DURING THE FIRST HALF OF 2019; CONSOLIDATED REVENUES INCREASE BY 32% TO EUR 338 MILLION..NUMBER OF ACTIVE CUSTOMERS INCREASES BY 50% TO 4.2 MILLION..H1 REVENUES FOR DACH-SEGMENT GROW BY +27% TO EUR 298 MILLION..GUIDANCE FOR 2019 FISCAL YEAR CONFIRMED.H1 INTERNATIONAL REVENUES RISE BY +83% TO EUR 40 MILLION..

Shop Apotheke Europe Says Break-Even Is Expected In 2020

May 15 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-NEWS: SHOP APOTHEKE EUROPE REPORTS SALES GROWTH OF 33% IN THE FIRST QUARTER OF 2019..Q1 NUMBER OF ORDERS ROSE BY 55% COMPARED TO CORRESPONDING PERIOD LAST YEAR, REACHING 3.1 MILLION (Q1 2018: 2.1 MILLION).CONSOLIDATED Q1 REVENUES ROSE BY 33% TO EUR 174.7 MILLION.Q1 CONSOLIDATED GROSS EARNINGS BY 42%, FROM EUR 23.0 MILLION DURING FIRST THREE MONTHS OF 2018 TO EUR 32.6 MILLION.OUTLOOK 2019: EXPECTS SHOP APOTHEKE EUROPE TO ACCELERATE ITS ORGANIC GROWTH RATE TO APPROXIMATELY 30% (2018: 25%).PLANNED (ADJUSTED) EBITDA MARGIN IS PROJECTED TO BE AT LEVEL OF PREVIOUS YEAR OR SLIGHTLY BETTER..BREAK-EVEN IS EXPECTED IN 2020..OUTLOOK 2019: SHOP APOTHEKE EUROPE TO INCREASE CONSOLIDATED REVENUES TO CA. EUR 700 MILLION.

Shop Apotheke Europe Completes EUR 50 Mln Capital Increase

April 10 (Reuters) - SHOP APOTHEKE EUROPE NV <SAEG.DE>::SUCCESSFULLY COMPLETES C. EUR 50M CAPITAL INCREASE BY PLACING 1.39M NEW BEARER SHARES AND A EUR 60M CONCURRENT TAP OF ITS EXISTING CONVERTIBLE BONDS DUE APRIL 2023 WITH INSTITUTIONAL INVESTORS..NEW SHARES ISSUE PRICE: EUR 36.00.NEW BONDS ISSUE PRICE AT 99.47%, PLUS ACCRUED INTEREST OF 2.2253% OF PAR.NET PROCEEDS TO FUND CONTINUOUS GROWTH STRATEGY.

Shop Apotheke Europe Q1 Revenue Up 33 Pct At EUR 174 Million

April 3 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-NEWS: SHOP APOTHEKE EUROPE STARTS THE YEAR STRONGLY: CONSOLIDATED REVENUES INCREASE BY 33% TO OVER EUR 174 MILLION DURING THE FIRST QUARTER..FORECAST FOR WHOLE 2019 FISCAL YEAR CONFIRMED..CONSOLIDATED REVENUES GROWING BY 33% TO MORE THAN EUR 174 MILLION DURING Q1 OF 2019.

Shop Apotheke Europe FY Revenues Up At EUR 540 Mln

March 15 (Reuters) - SHOP APOTHEKE EUROPE NV <SAEG.DE>::INCREASES REVENUES BY OVER 90% TO EUR 540 MILLION IN 2018.2018 CONSOLIDATED ADJUSTED EBITDA MARGIN IMPROVED TO -2.2% (PREVIOUS YEAR: -3.0%).2019: FOCUS ON ORGANIC GROWTH.2019 FORECAST I: ACCELERATION OF ORGANIC GROWTH TO CA. 30% WITH REVENUES OF AROUND EUR 700 MILLION.2019 FORECAST II: ADJUSTED EBITDA LEVEL AT LEAST ON LEVEL OF PREVIOUS YEAR.FY CONSOLIDATED REVENUES ROSE BY 90%, FROM EUR 284 MILLION IN 2017 TO EUR 540 MILLION (ORGANIC 25%).

​Shop Apotheke Europe Reaches Growth Targets In 2018

Jan 22 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-NEWS: ​SHOP APOTHEKE EUROPE REACHES 2018 GROWTH TARGET; CONSOLIDATED REVENUES OF EUR 540 MILLION..CONSOLIDATED REVENUES INCREASE BY +90% TO EUR 540 MILLION.INTEGRATION AND MOVE OF NU3 COMPLETED ACCORDING TO PLAN IN JANUARY 2019.COMPANY'S DYNAMIC REVENUE GROWTH IS BASED ON SUCCESSFUL RISE IN NUMBER OF ACTIVE CUSTOMERS ACROSS EUROPE, FROM 2.7 MILLION END OF 2017 TO AROUND 3.5 MILLION AT END OF 2018.

Shop Apotheke Europe 9-Month Consolidated Gross Earnings Up At EUR 71.8 Mln

Nov 14 (Reuters) - SHOP APOTHEKE EUROPE NV <SAEG.DE>::INCREASES CONSOLIDATED REVENUES BY +103% TO OVER EUR 388 MILLION FOR THE FIRST NINE MONTHS OF 2018..INCREASES CONSOLIDATED REVENUES BY +103% TO OVER EUR 388 MILLION FOR FIRST NINE MONTHS OF 2018.9-MONTH CONSOLIDATED GROSS EARNINGS INCREASE BY 77% TO EUR 71.8 MILLION.9-MONTH ADJUSTED CONSOLIDATED SEGMENT EBITDA FROM EUR -1.0 MILLION TO EUR +4.8 MILLION.ON TRACK TO MEET ITS FY RECENTLY INCREASED REVENUE PROJECTION (FROM EUR 540 MILLION TO EUR 570 MILLION).EXPECTS AN ADJUSTED EBITDA MARGIN OF UP TO -2% FOR 2018 FISCAL YEAR (PREVIOUS FORECAST: -0.5%).

Shop Apotheke Europe Revised forecast for financial year 2018

Nov 13 (Reuters) - Shop Apotheke Europe NV <SAEG.DE>::DGAP-ADHOC: SHOP APOTHEKE EUROPE: REVISED FORECAST FOR FINANCIAL YEAR 2018.MANAGEMENT BOARD IS CONFIDENT TO ACHIEVE RECENTLY INCREASED SALES FORECAST OF EUR 540 MILLION TO EUR 570 MILLION FOR FY.SEES FY 2018 ADJUSTED EBITDA MARGIN IS EXPECTED TO BE UP TO -2%.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up